Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

535 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma.
Vora P, Venugopal C, Salim SK, Tatari N, Bakhshinyan D, Singh M, Seyfrid M, Upreti D, Rentas S, Wong N, Williams R, Qazi MA, Chokshi C, Ding A, Subapanditha M, Savage N, Mahendram S, Ford E, Adile AA, McKenna D, McFarlane N, Huynh V, Wylie RG, Pan J, Bramson J, Hope K, Moffat J, Singh S. Vora P, et al. Among authors: savage n. Cell Stem Cell. 2020 Jun 4;26(6):832-844.e6. doi: 10.1016/j.stem.2020.04.008. Epub 2020 May 27. Cell Stem Cell. 2020. PMID: 32464096 Free article.
Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma.
Qazi MA, Vora P, Venugopal C, Adams J, Singh M, Hu A, Gorelik M, Subapanditha MK, Savage N, Yang J, Chokshi C, London M, Gont A, Bobrowski D, Grinshtein N, Brown KR, Murty NK, Nilvebrant J, Kaplan D, Moffat J, Sidhu S, Singh SK. Qazi MA, et al. Among authors: savage n. Cancer Res. 2018 Sep 1;78(17):5023-5037. doi: 10.1158/0008-5472.CAN-18-0267. Epub 2018 Jun 26. Cancer Res. 2018. PMID: 29945963
In Vivo Murine Models of Brain Metastasis.
Singh M, Savage N, Singh SK. Singh M, et al. Among authors: savage n. Methods Mol Biol. 2019;1869:231-238. doi: 10.1007/978-1-4939-8805-1_19. Methods Mol Biol. 2019. PMID: 30324527
A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cells.
Manoranjan B, Chokshi C, Venugopal C, Subapanditha M, Savage N, Tatari N, Provias JP, Murty NK, Moffat J, Doble BW, Singh SK. Manoranjan B, et al. Among authors: savage n. Oncogene. 2020 Feb;39(7):1590-1599. doi: 10.1038/s41388-019-1086-x. Epub 2019 Nov 6. Oncogene. 2020. PMID: 31695152
Wnt activation as a therapeutic strategy in medulloblastoma.
Manoranjan B, Venugopal C, Bakhshinyan D, Adile AA, Richards L, Kameda-Smith MM, Whitley O, Dvorkin-Gheva A, Subapanditha M, Savage N, Tatari N, McKenna D, Bassey-Archibong B, Winegarden N, Hallett R, Provias JP, Yarascavitch B, Ajani O, Fleming A, Bader GD, Pugh TJ, Doble BW, Singh SK. Manoranjan B, et al. Among authors: savage n. Nat Commun. 2020 Aug 28;11(1):4323. doi: 10.1038/s41467-020-17953-4. Nat Commun. 2020. PMID: 32859895 Free PMC article.
A Patient-Derived Xenograft Model of Glioblastoma.
Chokshi CR, Savage N, Venugopal C, Singh SK. Chokshi CR, et al. Among authors: savage n. STAR Protoc. 2020 Nov 21;1(3):100179. doi: 10.1016/j.xpro.2020.100179. eCollection 2020 Dec 18. STAR Protoc. 2020. PMID: 33377073 Free PMC article.
Advances in Immunotherapy for Adult Glioblastoma.
Chokshi CR, Brakel BA, Tatari N, Savage N, Salim SK, Venugopal C, Singh SK. Chokshi CR, et al. Among authors: savage n. Cancers (Basel). 2021 Jul 7;13(14):3400. doi: 10.3390/cancers13143400. Cancers (Basel). 2021. PMID: 34298615 Free PMC article. Review.
Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence.
Bakhshinyan D, Adile AA, Liu J, Gwynne WD, Suk Y, Custers S, Burns I, Singh M, McFarlane N, Subapanditha MK, Qazi MA, Vora P, Kameda-Smith MM, Savage N, Desmond KL, Tatari N, Tran D, Seyfrid M, Hope K, Bock NA, Venugopal C, Bader GD, Singh SK. Bakhshinyan D, et al. Among authors: savage n. Sci Adv. 2021 Dec 10;7(50):eabi5568. doi: 10.1126/sciadv.abi5568. Epub 2021 Dec 8. Sci Adv. 2021. PMID: 34878832 Free PMC article.
CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment.
Seyfrid M, Maich WT, Shaikh VM, Tatari N, Upreti D, Piyasena D, Subapanditha M, Savage N, McKenna D, Mikolajewicz N, Han H, Chokshi C, Kuhlmann L, Khoo A, Salim SK, Archibong-Bassey B, Gwynne W, Brown K, Murtaza N, Bakhshinyan D, Vora P, Venugopal C, Moffat J, Kislinger T, Singh S. Seyfrid M, et al. Among authors: savage n. J Immunother Cancer. 2022 Jan;10(1):e003289. doi: 10.1136/jitc-2021-003289. J Immunother Cancer. 2022. PMID: 35017149 Free PMC article.
535 results